From Knowledge to Action: Advances in Herpes Zoster Vaccine and Vaccination
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines against Tropical and other Infectious Diseases".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 468
Special Issue Editors
Interests: infectious diseases; immunization campaign; health promotion; health inequalities
Interests: infectious disease; NCDs; risk factors; epidemiology; prevention; meta-analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Herpes zoster, also known as shingles, is a condition caused by the reactivation of the varicella zoster virus. Public knowledge about shingles and its vaccination is often limited, leading to misconceptions and underestimation of the disease's severity. Vaccine uptake is uneven, with disparities based on socioeconomic status, race, ethnicity, and geography due to limited access, financial barriers, and inconsistent healthcare recommendations. Two main vaccines are available: Shingrix (recombinant subunit) and Zostavax (live attenuated). The former is preferred for immunocompromised individuals, because it is a non-live vaccine, reducing the risks associated with live vaccines like Zostavax. Effective vaccine campaigns, vital for increasing herpes zoster vaccination rates, are starting globally. Strategies should focus on raising awareness about the disease and the vaccination benefits and addressing common misconceptions. Leveraging media platforms and engaging healthcare providers in proactive outreach are required to increase vaccination coverage.
Dr. Giulia Silvestrini
Dr. Manuela Chiavarini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- knowledge, attitudes, and practices regarding herpes zoster vaccination
- vaccine hesitancy
- vaccine uptake and inequality
- efficacy, reactogenicity, and safety of herpes zoster vaccine
- efficacy of different vaccines
- the role of different type of herpes zoster vaccine in different target of population
- active campaign
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
